Corvus Pharmaceuticals (CRVS) Property, Plant & Equipment (Net) (2015 - 2026)

Corvus Pharmaceuticals (CRVS) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 518.26 Mn
10 Corvus Pharmaceuticals 1.18 Bn 942.24 Mn - 282,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 282,000.00
Mar 31, 2026 282,000.00
Dec 31, 2025 220,000.00
Dec 31, 2025 220,000.00
Sep 30, 2025 221,000.00
Sep 30, 2025 221,000.00
Jun 30, 2025 249,000.00
Jun 30, 2025 249,000.00
Mar 31, 2025 165,000.00
Mar 31, 2025 165,000.00
Dec 31, 2024 151,000.00
Dec 31, 2024 151,000.00
Sep 30, 2024 171,000.00
Sep 30, 2024 171,000.00
Jun 30, 2024 192,000.00
Jun 30, 2024 192,000.00
Mar 31, 2024 213,000.00
Mar 31, 2024 213,000.00
Dec 31, 2023 236,000.00
Dec 31, 2023 236,000.00